Prolactin Promoter Polymorphism (−−1149 G//T) is Associated with ANTI––DNA Antibodies in Mexican Patients with Systemic Lupus Erythematosus

By Montoya-Dííaz Eduardo   Cervera-Castillo Hernando   Cháávez-Sáánchez Luis   Legorreta-Haquet Ma Victoria   Sáánchez-Gonzáález Lourdes   Cháávez-Rueda Karina   Blanco-Favela Francisco  

Immunological Investigations, Vol. 40, Iss. 6, 2011-01 ,pp. : 614-626

Informa Healthcare

Access to resources Recommend Favorite

Utilization of the V_H4-21 Gene Segment by Anti-DNA Antibodies from Patients with Systemic Lupus Erythematosus

By Stevenson F.K.   Longhurst C.   Chapman C.J.   Ehrenstein M.   Spellerberg M.B.   Hamblin T.J.   Ravirajan C.T.   Latchman D.   Isenberg D.  

Journal of Autoimmunity, Vol. 6, Iss. 6, 1993-12 ,pp. : 809-825

Academic Press

Access to resources Recommend Favorite

Are anti-ribosomal P protein antibodies relevant in systemic lupus erythematosus?

By Kiss Emese  

Clinical Reviews in Allergy and Immunology, Vol. 32, Iss. 1, 2007-02 ,pp. : 37-46

Humana Press, Inc

Access to resources Recommend Favorite

Identification of Endothelial Cell Membrane Proteins that Bind Anti-DNA Antibodies from Patients with Systemic Lupus Erythematosus by Direct or Indirect Mechanisms

By Chan T.M.   Cheng I.K.P.  

Journal of Autoimmunity, Vol. 10, Iss. 5, 1997-10 ,pp. : 433-439

Academic Press

Access to resources Recommend Favorite

Cyclosporin and Plasmapheresis in Treatment of Progressive Systemic Lupus Erythematosus (pSLE)

By Schiel R.   Bambauer R.   Latza R.   Klinkmann J.  

Transfusion and Apheresis Science, Vol. 18, Iss. 1, 1997-03 ,pp. : 91-97

Elsevier

Access to resources Recommend Favorite